Outpatient Intraperitoneal Catumaxomab Therapy for Malignant Ascites Related to Advanced Gynecologic Neoplasms.
about
Bispecific Antibodies as a Development Platform for New Concepts and Treatment Strategies.Pancreas Adenocarcinoma: Ascites, Clinical Manifestations, and Management Implications.New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness.Bi-specific and tri-specific antibodies- the next big thing in solid tumor therapeutics
P2860
Outpatient Intraperitoneal Catumaxomab Therapy for Malignant Ascites Related to Advanced Gynecologic Neoplasms.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Outpatient Intraperitoneal Cat ...... dvanced Gynecologic Neoplasms.
@ast
Outpatient Intraperitoneal Cat ...... dvanced Gynecologic Neoplasms.
@en
type
label
Outpatient Intraperitoneal Cat ...... dvanced Gynecologic Neoplasms.
@ast
Outpatient Intraperitoneal Cat ...... dvanced Gynecologic Neoplasms.
@en
prefLabel
Outpatient Intraperitoneal Cat ...... dvanced Gynecologic Neoplasms.
@ast
Outpatient Intraperitoneal Cat ...... dvanced Gynecologic Neoplasms.
@en
P2093
P2860
P1433
P1476
Outpatient Intraperitoneal Cat ...... dvanced Gynecologic Neoplasms.
@en
P2093
Ann Tabea Kurbacher
Christian Martin Kurbacher
Jutta Anna Kurbacher
Olympia Horn
Ralf Hildenbrand
Reinhardt Bollmann
Susanne Herz
P2860
P304
P356
10.1634/THEONCOLOGIST.2015-0076
P577
2015-09-28T00:00:00Z